MedPath

Perioperative Rehabilitation Therapy in Patients Undergoing Liver Transplantation

Not Applicable
Not yet recruiting
Conditions
Liver Transplantation
Sarcopenia
Interventions
Dietary Supplement: BCAA Nutritional Intervention
Dietary Supplement: Standard Nutritional Therapy
Behavioral: Muscle Rehabilitation Training
Registration Number
NCT06591507
Lead Sponsor
Zhejiang University
Brief Summary

Patients undergoing liver transplantation frequently experience a reduction in skeletal muscle mass, malnutrition, and decreased levels of physical activity. These complications can adversely affect early postoperative recovery and the therapeutic effect of the transplant. This clinical study aims to investigate the effects of nutritional supplementation and rehabilitation therapy on sarcopenia associated with liver transplantation in adults. The goal is to establish a comprehensive perioperative intervention strategy to reduce the incidence of postoperative sarcopenia and improve transplantation outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
750
Inclusion Criteria
  1. Age between 18 and 70 years.
  2. Patients with end-stage liver disease who meet the criteria for liver transplantation (for liver cancer cases, only recipients meeting specific standards are included).
  3. Complete clinical information, including documented pre-transplant muscle status (e.g., preoperative CT scans and handgrip strength tests).
  4. High compliance with treatment, fully capable of independent action or having at least one assistant.
  5. No contraindications to the planned interventions.
Exclusion Criteria
  1. Presence of musculoskeletal disorders before transplantation, such as myositis, idiopathic muscle atrophy, or history of hip surgery within the past three months.
  2. Coexisting severe cardiovascular or cerebrovascular diseases, infectious diseases, or epilepsy.
  3. Liver transplantation due to autoimmune liver disease or drug-induced liver failure.
  4. Re-transplantation, multi-organ transplantation, living donor liver transplantation, split liver transplantation, or pediatric liver transplantation.
  5. ABO-incompatible liver transplantation.
  6. Incomplete clinical information.
  7. Difficulty in follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Preoperative and Postoperative BCAA Nutritional InterventionBCAA Nutritional Intervention-
Preoperative and Postoperative BCAA Nutritional Intervention + Postoperative Muscle RehabilitationBCAA Nutritional Intervention-
Preoperative and Postoperative BCAA Nutritional Intervention + Postoperative Muscle RehabilitationMuscle Rehabilitation Training-
Postoperative BCAA Nutritional InterventionBCAA Nutritional Intervention-
Postoperative Muscle RehabilitationMuscle Rehabilitation Training-
Standard Nutritional TherapyStandard Nutritional Therapy-
Primary Outcome Measures
NameTimeMethod
2-year overall survivalFrom enrollment to the end of follow-up at 2 years

At the 2-year mark, record the survival status of each patient (alive or deceased).

Secondary Outcome Measures
NameTimeMethod
Muscle massFrom enrollment to the end of treatment at 6 months

Muscle mass can be assessed using various methods, including CT-based Skeletal Muscle Index (SMI) calculation at the L3 vertebra, which measures the cross-sectional area of muscle normalized by height; handgrip strength testing, which evaluates muscle function; bioelectrical impedance analysis (BIA) for body composition; MRI for precise muscle volume measurements; and dual-energy X-ray absorptiometry (DXA) for assessing lean body mass. These methods provide a comprehensive evaluation of muscle health.

© Copyright 2025. All Rights Reserved by MedPath